Position in ENTA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,909,121
-$1,451,382 QoQ
Shares Held
309,511
-8.9% QoQ
Ownership
1.06%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 85%
Shared 0%
None 15%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026MORGAN STANLEY holds $15,425,095,484 across 521 Biotechnology names. ENTA ranks #183 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RPRX |
Royalty Pharma plc
|
43,571,633 | $2,090,131,227 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
51,828,325 | $1,435,644,595 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,188,881 | $1,423,962,911 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,319,329 | $1,019,366,352 | |
| 5 | TECH |
BIO-TECHNE Corp
|
8,532,873 | $445,927,935 | |
| 6 | MRNA |
Moderna, Inc.
|
8,471,263 | $430,340,154 | |
| 7 | ARGX |
Argenx SE
|
560,711 | $409,459,203 | |
| 8 | APLS |
Apellis Pharmaceuticals, Inc.
|
10,042,399 | $404,005,708 |
All Filings in ENTA
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,909,121 | 309,511 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $5,360,503 | 339,918 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $3,383,089 | 282,631 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $2,166,132 | 286,526 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $2,679,908 | 485,491 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $7,024,167 | 1,221,595 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $11,425,542 | 1,102,852 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $18,891,566 | 1,456,559 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $35,708,228 | 2,045,145 | Shares | Defined | 2024-08-16 | |
| 2023-12-31 | $11,038,472 | 1,173,058 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,306,198 | 564,566 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $6,576,260 | 307,302 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $5,335,974 | 131,948 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $6,444,179 | 138,525 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $9,423,427 | 181,674 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $11,575,190 | 244,874 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $11,854,883 | 166,548 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $9,427,438 | 126,069 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $9,216,396 | 162,232 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $7,754,867 | 176,207 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $7,193,370 | 145,851 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $6,658,366 | 158,156 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $4,131,872 | 90,255 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,126,676 | 62,272 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $3,505,878 | 68,168 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||